Efficacy and safety profiles of programmed cell death-1/programmed cell death ligand-1 inhibitors in the treatment of triple-negative breast cancer: A comprehensive systematic review

Triple-negative breast cancer (TNBC) is associated with worse prognosis, with limited treatment regiments available and higher mortality rate. Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) showed great potentials in treating malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazarus, Gilbert, Audrey, Jessica, Iskandar, Anthony William Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886008/
https://www.ncbi.nlm.nih.gov/pubmed/31857857
http://dx.doi.org/10.4081/oncol.2019.425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886008/
https://www.ncbi.nlm.nih.gov/pubmed/31857857
http://dx.doi.org/10.4081/oncol.2019.425

Ejemplares similares